Heerlen, Netherlands and Geneva (ots/PRNewswire) - NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. NOT FOR GENERAL RELEASE IN THE UNITED STATES – SEE FURTHER INFORMATION BELOW. This announcement is not for release, publication or distribution, ...
Cambridge, England (ots/PRNewswire) - Abcam plc ("Abcam," "Company," "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces the appointment of Tommy Thomas as Vice President of Investor Relations. Tommy, who will be based in our Waltham, MA office, has over 20 years' experience in the life sciences sector, largely focused in the area of research tools. He joins ...
Poda Lifestyle and Wellness Ltd.
Vancouver, Bc (ots/PRNewswire) - PODA HOLDINGS, INC. ("PODA" or the "Company") (CSE: PODA) (FSE: 99L) (OTC: PODAF) is pleased to announce that, further to its news release dated May 13, 2022, the Company, together with Ryan Selby and Ryan Karkairan (the "Owners"), has completed the sale of substantially all of the assets and properties used in the Company's ...
Liverpool England and Philadelphia USA (ots) - --News Direct-- SAFETY INITIATIVE AND COMPLIANCE WILL SAVE AMERICAN HEALTHCARE INDUSTRY $1 BILLION British smart MedTech company NeedleSmart, which is pioneering disruptive technologies in the global healthcare sector, is expanding into the US healthcare market to ...
Geneva and Heerlen, Netherlands (ots/PRNewswire) - NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. NOT FOR GENERAL RELEASE IN THE UNITED STATES – SEE FURTHER INFORMATION BELOW. DSM and ...
Copenhagen (ots/PRNewswire) - MC2 Therapeutics A/S, a commercial stage pharmaceutical company, has named Lars Iversen, MD, DMSc an esteemed chair professor in dermatology at Aarhus University Hospital and at Aarhus University, its new full-time Chief Medical Officer (CMO) as of October 1st, 2022. Professor Lars Iversen will be a key member of the Executive Team at MC2 ...
Petach Tikvah, Israel (ots/PRNewswire) - KIMMTRAK has been approved in Canada and Australia for the treatment of an aggressive form of ocular melanoma and follows approval in the United States and the European Union Today, Medison Pharma ("Medison"), a global pharma company focused on providing access to highly ...
Petach Tikvah, Israel (ots/PRNewswire) - Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, announced today an exclusive multi-regional agreement with argenx to commercialize efgartigimod in 14 countries, including ...
VANCOUVER, Bc (ots/PRNewswire) - PODA HOLDINGS, INC. ("PODA" or the "Company") (CSE: PODA) (FSE: 99L) (OTC: PODAF) is pleased to announce that, further to its news release dated May 13, 2022 in respect of the proposed sale of all or substantially all of the Company's assets to Altria Client Services LLC ("ALCS"), a subsidiary of Altria Group, Inc. (NYSE: MO), it ...
Singapore (ots/PRNewswire) - - LUCIDITY data suggest that participants receiving hydromethylthionine mesylate (HMTM) decline at a rate substantially less than is typical in Alzheimer's based on published research - Safety profile is favourable and consistent with previous HMTM studies - TauRx will now pursue ...
Caesarea, Israel (ots/PRNewswire) - Cardiovascular data presented at EuroPCR 2022 demonstrates successful device performance during a TAVR procedure with no complications. Filterlex Medical Ltd., a cardiovascular medical device startup, announced today results from a first-in-human (FIH) study demonstrating the ...
Oxford, England (ots/PRNewswire) - - With strong support from the Government of Djibouti, this program will pilot a new Friendly™ mosquito control technology to combat the growing threat to the region posed by the rapidly spreading malaria vector, Anopheles stephensi. - Oxitec will work hand-in-hand with the ...
Heerlen, Netherlands and Geneva (ots/PRNewswire) - NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. NOT FOR GENERAL RELEASE IN THE UNITED ...
Geneva (ots/PRNewswire) - This announcement is not for release, publication or distribution, directly or indirectly (in whole or in part) in, into, or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction, including the United States, Canada, South Africa, Australia and Japan. In conjunction with ...
Amsterdam (ots/PRNewswire) - Today, Norgine Europe B.V. ("Norgine", the "Company"), a leading European specialty pharmaceutical company, announced that the Private Equity business within Goldman Sachs Asset Management will acquire a majority stake in the Company from the Stein Family, who will continue to own a significant stake in the Company. The transaction is a key milestone in Norgine's history, following over 110 ...
Petach Tikvah, Israel (ots/PRNewswire) - The latest geographic growth increases Medison's global footprint across 25 countries in four continents, further strengthening its commercial offering Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients ...
Yavne, Israel (ots/PRNewswire) - Accessible First-Line Contactless Glaucoma Care Now Available in Europe BELKIN Vision, the Israel-based medical device company committed to bringing an accessible first-line glaucoma laser treatment to market, announced today that it has been awarded CE Mark under Medical Device Regulation (MDR) from its notified body DEKRA, making it the first automated, non-contact glaucoma laser ...
Milan (ots/PRNewswire) - The new platform will be presented at the next EACR Liquid Biopsy conference to be held in Bergamo, Italy, on May 24th-26th, 2022 Tethis S.p.A announces the release of See.d®, the first universal blood sample preparator for liquid biopsy analysis. This innovative technology performs a ...
POCARED Diagnostics; European Investment Bank
Rehovot, Israel (ots/PRNewswire) - - First EIB support for medtech investment in Israel - Financing to accelerate development of rapid testing system to improve infectious disease diagnosis and antibiotics stewardship - Automated phenotypic testing, revolutionizing infectious diseases diagnostics from sample to ...
Caesarea, Israel (ots/PRNewswire) - Cardiovascular study results to be presented by Prof. Ran Kornowski, Director of the Cardiology Center, Rabin Medical Center at the EuroPCR 2022 conference in May Filterlex Medical Ltd., a cardiovascular medical device startup, announced today that it has completed its CAPTIS ...
Berlin/Lausanne/Barcelona/Munich (ots) - New investors with a successful track record in digital oncology support German Digital Therapeutics (DTx) company Fosanis to broaden patient access of Mika - an app-based DTx platform empowering people affected by cancer. Berlin-based digital health company Fosanis, the ...
Nijmegen, Netherlands and Wedel, Germany (ots/PRNewswire) - SYD985 Marketing Authorization Application Soon to Be Submitted to the EMA Byondis B.V., an independent, Dutch clinical stage biopharmaceutical company creating precision medicines, has entered into a License and Collaboration Agreement and a Supply ...
Parma, Italy, and Cleveland, Ohio (ots/PRNewswire) - - New investment will progress treatment of pulmonary arterial hypertension (PAH), a rare condition which causes high blood pressure in the blood vessels that supply the lungs and can lead to heart failure. - Current approved medications mainly address the ...
London (ots/PRNewswire) - Hikma Pharmaceuticals PLC (Hikma) confirms that it has not entered into any transaction with Opiant Pharmaceuticals, contrary to a PR Newswire announcement issued today indicating that Opiant Pharmaceuticals and Hikma have entered into a commercialisation and license agreement for OPNT003, Nasal Nalmefene, in Europe and the UK. About Hikma ...
Barcelona, Spain (ots/PRNewswire) - - The agreement with Dana-Farber Cancer Institute consists of using HER2DX®️ to analyze tumor samples from more than 500 patients with early-stage HER2+ breast cancer across three clinical trials (APT, ATEMPT, and DAPHNE). - The three completed studies were essential in establishing new anti-HER2-based treatment strategies for ...
Heidelberg, Germany, and Cambridge, Mass. (ots/PRNewswire) - Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced that data from the second pivotal Phase 3 trial (ESSENCE-2) evaluating the investigational ...
Tel Aviv, Israel (ots/PRNewswire) - BENDIT Technologies, a company focused on the development of a steerable microcatheter platform, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Bendit21 microcatheter for treatment in the neuro, peripheral, and coronary ...
Zug, Switzerland (ots/PRNewswire) - In a new publication, the company's flagship compound proves effective in targeting the harmful pathogen while preserving a healthy microbiome Micreos Pharmaceuticals today announces findings from a study proving the effectiveness of XZ.700, a novel antibacterial enzyme, in ...
Aberdeen, Scotland and Singapore (ots/PRNewswire) - - Significant milestone in the only late-stage clinical trial targeting tau pathology of Alzheimer's - TauRx on track to announce top line results in May - Trial aims to confirm efficacy of first tau-based treatment for Alzheimer's TauRx Pharmaceuticals Ltd, a global leader in tau-based Alzheimer's Disease (AD) research, has announced that the last patient has completed ...